ArticleJournal of gastric cancer2024

Reply: Comment on The Necessity of Guidance: Optimizing Adjuvant Therapy for Stage II/III MSI-H Gastric Cancer Through the Interplay of Evidence, Clinical Judgment, and Patient Preferences.

In-Ho Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.